Commercialisation of Tyrian’s ReadRite® Test Kicks Off in Canada
May 21 2009 - 8:00AM
Business Wire
Tyrian Diagnostics Limited (ASX:TDX) announced today that
the company has completed the manufacture of an initial order of
commercial ReadRite� alpha-amylase kits for Bayer CropScience AG,
intended to be rolled-out in the North American market. The
ReadRite test, which detects alpha-amylase in wheat, performed very
well in an independent official evaluation which confirmed the test
as a reliable measure for the determination of wheat quality.
This test, formerly referred to as WheatRite, is being marketed
in Canada as the ReadRite alpha-amylase test for use with Tyrian�s
Reader. The test provides grain industry stakeholders with a rapid,
easy to use, and quantitative method for determining the quality of
wheat at Point of Need.
�The results of the evaluation and the launch of the ReadRite
product is a major accomplishment for Tyrian, and validates our
DiagnostIQ� platform in the agriculture industry,� said Jenny
Harry, PhD, Chief Executive Officer of Tyrian Diagnostics. �We have
developed a strong working relationship with Bayer CropScience, and
we look forward to continued collaboration on this and future
products.�
Tyrian will continue to manufacture ReadRite� test kits in
house, whilst concurrently establishing outsourced manufacturing of
the kits to meet forecast sales increases in North America and
other regions.
About ReadRite alpha-amylase test
The ReadRite� alpha-amylase test is a rapid wheat quality test
that can be completed in five minutes and enables growers to make
an on-farm assessment of the extent of rain damage to a crop in
order to separate sound grain from damaged grain. The test is
available as a rapid visual test that can be interpreted without
instrumentation, or used in conjunction with the ReadRite� Reader
to provide a more definitive quantitative result. Rain damage has a
significant impact on the pricing of harvested wheat. Grading must
be conducted by trading authorities prior to sale and/or export,
but also may be performed at multiple points in the chain, from
on-farm to wheat processor, to monitor and confirm grain
quality.
About Tyrian�s DiagnostIQ Reader
Tyrian�s DiagnostIQ Reader is a proprietary device that utilizes
optical detection technology combined with customized software to
provide a quantitative measure of the level of diagnostic targets
in samples processed in Tyrian�s point of need DiagnostIQ tests.
The Reader can be configured to detect diagnostic targets in a wide
range of sample types, and therefore has utility in the healthcare,
agricultural, and veterinary fields.
About Tyrian Diagnostics
Tyrian Diagnostics (ASX:TDX) is a diagnostics company with
expertise in biomarker discovery and validation and diagnostic test
development with a core focus on respiratory and infectious
diseases. Tyrian�s product pipeline includes:
- ReadRite� tests for crop quality
management, which are partnered with Bayer CropScience; and
- a rapid test for active
tuberculosis, in collaboration with the US-based group Becton,
Dickinson and Company.
In addition, Tyrian has many partnering opportunities in
alternative fields, given its capabilities to work across the
entire spectrum of diagnostic test development � from
identification and isolation of biomarkers, point-of-need test
design, clinical development or field testing to final product.
Core technology of the company includes the DiagnostIQ test format,
a handheld device that allows rapid and easy detection of protein
markers associated with particular medical, veterinary or
agricultural conditions.
Additional information about Tyrian Diagnostics can be found at
www.tyriandx.com
Tyrian Diagnostics (ASX:TDX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Tyrian Diagnostics (ASX:TDX)
Historical Stock Chart
From Jan 2024 to Jan 2025
